Search research articles
Contact Us
Filters
Showing results (121-130 of 1,324) with videos related to
Page
of 133
Sort By:
Radiologic Clinics of North America
|
February 9, 2000
New treatment strategies in advanced prostate cancer
E J Small, D M Reese
Seminars in Oncology
|
January 8, 2003
Complementary and alternative therapies in prostate cancer
William K Oh, Eric J Small
Critical Reviews in Oncology/Hematology
|
July 10, 2003
The potential for prostate cancer immunotherapy
Brian I Rini, Eric J Small
Urology
|
March 1, 1994
Prostate-specific antigen decline after casodex withdrawal: evidence for an antiandrogen withdrawal syndrome
E J Small, P R Carroll
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 3, 2009
The selection of hormonal therapy in prostate cancer: who, when, and for how long?
Charles J Ryan, Eric J Small
The Urologic Clinics of North America
|
June 11, 1999
Secondary hormonal manipulations in hormone refractory prostate cancer
D M Reese, E J Small
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Second-line hormonal therapy for advanced prostate cancer: a shifting paradigm
E J Small, N J Vogelzang
Urology
|
January 30, 2004
Role of secondary hormonal therapy in the management of recurrent prostate cancer
Charles J Ryan, Eric J Small
Trends in Endocrinology and Metabolism: TEM
|
September 11, 2004
Gut hormones and the control of appetite
Caroline J Small, Stephen R Bloom
Cancer Cell
|
July 14, 2012
The future of cancer treatment: will it include immunotherapy?
Jeffrey A Bluestone, Eric J Small
Page
of 133
Search research articles
Search
Showing results (121-130 of 1,324) with videos related to
Sort By:
Page
of 133
Radiologic Clinics of North America
|
February 9, 2000
New treatment strategies in advanced prostate cancer
E J Small, D M Reese
Seminars in Oncology
|
January 8, 2003
Complementary and alternative therapies in prostate cancer
William K Oh, Eric J Small
Critical Reviews in Oncology/Hematology
|
July 10, 2003
The potential for prostate cancer immunotherapy
Brian I Rini, Eric J Small
Urology
|
March 1, 1994
Prostate-specific antigen decline after casodex withdrawal: evidence for an antiandrogen withdrawal syndrome
E J Small, P R Carroll
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 3, 2009
The selection of hormonal therapy in prostate cancer: who, when, and for how long?
Charles J Ryan, Eric J Small
The Urologic Clinics of North America
|
June 11, 1999
Secondary hormonal manipulations in hormone refractory prostate cancer
D M Reese, E J Small
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Second-line hormonal therapy for advanced prostate cancer: a shifting paradigm
E J Small, N J Vogelzang
Urology
|
January 30, 2004
Role of secondary hormonal therapy in the management of recurrent prostate cancer
Charles J Ryan, Eric J Small
Trends in Endocrinology and Metabolism: TEM
|
September 11, 2004
Gut hormones and the control of appetite
Caroline J Small, Stephen R Bloom
Cancer Cell
|
July 14, 2012
The future of cancer treatment: will it include immunotherapy?
Jeffrey A Bluestone, Eric J Small
Page
of 133